A review of albuminuria testing rates in people with diabetes mellitus: poor guideline adherence

Abstract

Diabetes mellitus and chronic kidney disease (CKD) are prevalent conditions affecting a significant portion of the Australian population. Urinary albumin testing, particularly through the urine albumin-to-creatinine ratio (uACR), is essential for screening, prognostication, and guiding treatment in patients with diabetes and CKD. Despite recommendations for annual screening among high-risk populations such as those with diabetes, recent studies indicate disturbingly low rates of albuminuria testing. This narrative literature review aims to examine rates of uACR testing in these populations, focusing on recent studies across various clinical settings and geographical regions. A systematic sea..